Senator Van Hollen to Spotlight Maryland Scientific and Economic Development Advancements

Maryland is among the top tier of states in the size and concentration of its bioscience and biomedical research complex 1

--()--Senator Van Hollen will join the leaders of Maryland biotechnology company GlycoMimetics for a tour of the company’s facilities before participating in a roundtable discussion on the economic and societal value of biotech innovation.

Senator Van Hollen will learn more about prospects for, and impediments to, the continued growth of this high-wage industry in Maryland. The Senator also will discuss the potentially significant effects of the federal health care policy and budget debates.



Tour and Roundtable Discussion at GlycoMimetics


Maryland Senator Chris Van Hollen

Jim Greenwood, President & CEO, BIO

Rachel King, CEO, GlycoMimetics, Inc.

Other senior leadership from GlycoMimetics



Friday, December 8, 2017 from 9:45 am – 11:00 am


9708 Medical Center Drive
Rockville, MD 20850

Media requested to RSVP to George Goodno,


About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.


Biotechnology Innovation Organization
George Goodno, 202-962-6660

Release Summary

MD Senator Van Hollen will tour a biotech lab & attend a round table discussion on the economic & societal value of biotech innovation. Open to press.


Biotechnology Innovation Organization
George Goodno, 202-962-6660